GlassScriptPhysician profile
Rebecca Anne Shaw
NPI 1003405739
$703.14
in general payments reported to CMS, 2019-2025
15 companies · $20.35 in 2025
The $20.35 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $62.42 · 2023: $562 · 2024: $58.01 · 2025: $20.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $195.22 | 2023 | Abilify Maintena, Rexulti, Abilify Mycite |
| Indivior INC. | $72.76 | 2023 | Sublocade |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $67.61 | 2022-2023 | |
| Boston Scientific Corporation | $65.91 | 2023-2024 | Click, Wavewriter Alpha Prime 16 |
| Janssen Pharmaceuticals, INC | $61.11 | 2022-2023 | Spravato |
| Alkermes, INC. | $41.51 | 2023 | Lybalvi, Vivitrol |
| Corium, LLC | $38.81 | 2023 | Azstarys |
| Tris Pharma INC | $29.71 | 2023 | Dyanavel Xr |
| Axsome Therapeutics, INC. | $25.89 | 2023 | Auvelity |
| Ironshore Pharmaceuticals INC. | $21.94 | 2023 | Jornay Pm |
| Vertical Pharmaceuticals, LLC | $20.35 | 2025 | Relexxii |
| Tempus Ai, INC | $19.19 | 2024 | Tempus Pixel |
| Abbvie INC. | $15.12 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.94 | 2023 | Trintellix |
| Idorsia Pharmaceuticals US INC | $13.07 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.